| Reporting Organization: | PAHO - Pan American Health Organization |
|---|---|
| Total Budget ($CAD): | $ 10,421,254 |
| Timeframe: | March 25, 2010 - January 31, 2013 |
| Status: | Completion |
| Contact Information: | Unspecified |
PAHO - Pan American Health Organization
Unspecified
| South America - $ 5,052,223.94 (48.48%) | |
|
|
|
| Caribbean - $ 3,157,639.96 (30.30%) | |
|
|
|
| Central America - $ 2,211,390.10 (21.22%) | |
|
|
|
| Infectious & Communicable Diseases (100 %) | |
|
|
|
The goal of this project is to reduce illness and deaths among children due to vaccine-preventable diseases in Latin America and the Caribbean by focussing on municipalities with vaccine coverage under 95%. The project aims to increase vaccination coverage with quality supplies and surveillance by strengthening the Regional Expanded Program on Immunization in ways that protect the achievements to date and meet new challenges in immunization programming. This project supports basic routine immunization programming through the Canadian International Immunization Initiative (CIII), which CIDA has funded since 1998. The CIII has supported three phases of the Pan American Health Organization’s (PAHO) Immunization in the Americas program, which aims to help countries in the Americas strengthen their routine national immunization programs. The PAHO program focuses on: improving the quality of vaccines and syringes used in national immunization programs; supporting innovative approaches to improving immunization uptake among hard-to-reach groups; strengthening laboratory capacity for the diagnosis of vaccine-preventable childhood diseases; and developing surveillance systems for the detection and management of vaccine-preventable diseases.
| Gender and age: | Under-5 children |
|---|---|
| Total Direct Population: | Unspecified |
Unspecified
Return to topUnspecified
Results achieved as of the end of the project (January 2013) include: (i) developing plans of action to improve vaccination coverage in 33 countries by reaching poorly performing municipalities; and (ii) helping to strengthen National Regulatory Authorities through vaccine licensing, vaccine lot release, vaccine laboratory testing, Good Manufacturing Practices inspection, clinical evaluations, and post-marketing surveillance. Twenty-one countries have achieved more than 95% vaccination coverage at the national level, 2,000 health professionals have been trained, and a total of 1,077,643 children under one year of age have benefitted from the project by receiving routine immunization. These results have contributed to the extraordinary progress that Latin American countries have made in providing their populations with protection against vaccine-preventable diseases. These countries have achieved sustained high national immunization coverage rates, eradicated polio, interrupted endemic measles and rubella virus transmission, and been on the forefront of introducing new sustainable vaccines.
